Nobuhiko Imahashi - Concepedia

Author

Nobuhiko Imahashi

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Imahashi Nobuhiko, N Imahashi, N. Imahashi, Nobuhiko IMAHASHI, Nobuhiko Imahashi, Toshio Yabe, for the Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation, for the Nagoya Blood and Marrow Transplantation Group

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Nagoya University National Hospital Organization Japanese Red Cross Nagoya Daiichi Hospital Nagoya Medical Center

About

Nobuhiko Imahashi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	685
2	Cell Biology	9	9	569
3	Health Sciences	3	3	46
4	Blood Transplantation	2	2	26
5	Allergy	1	1	35

Nobuhiko Imahashi

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells Keisuke Watanabe, Seitaro Terakura, Anton C. Martens, The Journal of Immunology	2014	280
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells May Daher, Rafet Başar, Elif Gokdemir, Blood	2020	272
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells Hila Shaim, Mayra Shanley, Rafet Başar, Journal of Clinical Investigation Cell TherapyImmunologyImmune RegulationImmunoeditingImmunotherapeutics	2021	234
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway Kimie Kondo, Hila Shaim, Philip A. Thompson, Leukemia InflammationCytokineAutoimmune DiseaseImmune RegulationImmunology	2017	118
Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease Satoshi Nishiwaki, Seitaro Terakura, Masafumi Ito, Blood	2009	69
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation Takuya Sekine, David Marín, Kai Cao, Blood	2016	62
A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy Abdullah Alsuliman, Stanley H. Appel, David R. Beers, Cytotherapy Regenerative MedicineCell TherapyAmyotrophic Lateral SclerosisCellular TherapiesT-regulatory Cell	2016	52
SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer Kazuhiro Matsuoka, Nobuhiko Imahashi, Miki Ohno, Journal of Biological Chemistry Virus StructureSignal TransductionViral ImmunityViral PathogenesisImmunology	2022	47
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation Li Li, Han Chen, David Marín, Blood Advances	2019	37
Dexamethasone Palmitate Ameliorates Macrophages-Rich Graft-versus-Host Disease by Inhibiting Macrophage Functions Satoshi Nishiwaki, Takayuki Nakayama, Makoto Murata, PLoS ONE ImmunologyImmune RegulationSuch GvhdInnate ImmunityDermatology	2014	36

Page 1